SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-056292
Filing Date
2017-11-03
Accepted
2017-11-03 17:16:08
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv477740_10q.htm 10-Q 368391
2 EXHIBIT 31.1 tv477740_ex31-1.htm EX-31.1 8118
3 EXHIBIT 31.2 tv477740_ex31-2.htm EX-31.2 8110
4 EXHIBIT 32.1 tv477740_ex32-1.htm EX-32.1 3623
5 EXHIBIT 32.2 tv477740_ex32-2.htm EX-32.2 3592
6 GRAPHIC tv477740_img01.jpg GRAPHIC 12959
  Complete submission text file 0001144204-17-056292.txt   2402584

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ntrp-20170930.xml EX-101.INS 315543
8 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20170930.xsd EX-101.SCH 27178
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntrp-20170930_cal.xml EX-101.CAL 23013
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntrp-20170930_def.xml EX-101.DEF 209951
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20170930_lab.xml EX-101.LAB 209324
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20170930_pre.xml EX-101.PRE 222946
Mailing Address 205 EAST 42ND STREET, 16TH FLOOR NEW YORK NY 10017
Business Address 205 EAST 42ND STREET, 16TH FLOOR NEW YORK NY 10017 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38045 | Film No.: 171177463
SIC: 2834 Pharmaceutical Preparations